[1] 段醒妹,张晔. 基质效应及其消除[J]. 赤峰学院学报,2008,24(4):17
DUAN XM, ZHANG Y. Matrix effect and its elimination[J]. J Chifeng Univ, 2008,24(4):17
[2] 李文魁,张杰,谢励诚,译. 《液相色谱-质谱(LC-MS)生物分析手册:最佳实践、实验方案及相关法规》[M]. 北京:科学出版社,2017:285
Translated by LI WK, ZHANG J,XIE LC. Handbook of LC-MC Bioanalysis: Best Practices, Experimental Protocols, and Regulations[M]. Beijing:Science Press, 2017:285
[3] LI WK, ZHANG J, TSE FL. Handbook of LC-MS Bioanalysis[M]. New York: John Wiley & Sons, 2013:369
[4] DU LH, WHIT RL. Reducing glycerophosphocholine lipid matrix interference effects in biological fluid assays by using high-turbulence liquid chromatography[J]. Rapid Commun Mass Spectrom, 2008, 22(21):3362
[5] FUREY A, MORIARTY M, BANE V, et al. Ion suppression: a critical review on causes, evaluation,prevention and applications [J]. Talanta,2013,115(10): 104
[6] LEVERENCE R, AVERY MJ, KAVETSKAIA O, et al. Signal suppression/enhancement in HPLC-ESI-MS/MS from concomitant medications[J]. Biomed Chromatogr, 2007, 21(11):1143
[7] MATUSZEWSKI BK, CONSTANZER ML, CHAVEZNG CM. Strategies for the assessment of matrix effect in quantitative bioan-alytical methods based on HPLC-MS/MS[J]. Anal Chem, 2003, 75(13):3019
[8] VISWANATHA AN, DIMOPOULOS J, KIRISITS C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachtherapy: results of a prospective trial and preliminary guidelines for standardized contours[J]. Int J Radiat Oncol Biol Phys, 2007, 68:491
[9] XIA YQ, JEMAL M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects[J]. Rapid Commun Mass Spectrom, 2009, 23:2125
[10] 刘晓云,陈笑艳,钟大放. 液相色谱-串联质谱生物分析方法的基质效应和对策[J]. 质谱学报, 2017, 38(4):388
LIU XY, CHEN XY, ZHONG DF. Matrix effects and countermeasure of liquid chromatography- tandem mass spectrometry in bioanalysis[J]. J Chin Mass Spectrom Soc, 2017, 38(4):388
[11] 冯晓杰,杜丽英,冯章英,等. LC-MS/MS法测定血药浓度的基质效应研究进展[J]. 中国新药杂志,2015,24(13): 1488
FENG XJ, DU LY, FENG ZY, et al. Research progress of matrix effect in determining blood concentration by LC-MS/MS[J]. Chin J New Drugs, 2015, 24(13): 1488
[12] FUREY A, MORIARTY M, BANE V, et al. Ion suppression: a critical review on causes, evaluation, prevention and applications[J]. Talanta, 2013, 115(115):104
[13] 王迪敏,孟繁华,刘金艳,等.LC-MS/MS 法测定兔血浆和组织中辣椒碱和二氢辣椒碱的浓度[J]. 中国新药杂志,2014,23(24):2866
WANG DM, MENG FH, LIU JY, et al. Determination of capsaicin(CAP) and dihydrocapsaicin(DHC) in rabbit plasma and tissue by LC-MS/MS method[J]. Chin J New Drugs, 2014,23(24):2866
[14] LINDEGARDH N, ANNERBERG A, WHITE NJ, et al. Development and validation of a liquid chromatographic-tandem mass pectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 862(1-2):227
[15] VAN EECKHAUT A,LANCKMANS K,SARRE S,et al.Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2009, 877(23): 2198
[16] ICH. Bioanalytical Method Validation and Study Sample Analysis M10[EB/OL]. (2022-05-24) [2024-09-06]. https://www. ich. org/page/multidisciplinary-guidelines
[17] 中华人民共和国药典2020年版.四部[S]. 2020: 119
ChP 2020. Vol Ⅳ[S]. 2020:119
[18] FDA. Bioanalytical Method Validation Guidance for Industry[EB/OL]. (2018-05) [2024-09-06]. https://www. fda. gov/drugs/development-approval-process-drugs/drug-approvals-and-databases
[19] FDA. Analytical Procedures and Methods Validation for Drugs and Biologics[EB/OL]. (2015-07) [2024-09-06]. https://www. fda. gov/drugs/development-approval-process-drugs/drug-approvals-and-databases
[20] EMA. Guideline on Validation of Bioanalytical Methods[EB/OL]. (2011-07-21) [2024-09-06]. https://www. ema. europa. eu/en/human-regulatory-overview/research-development/scientific-guidelines
[21] IBRAHIM J,UNDERHILL LH,TAYLOR JS, et al. Clinical response to eliglustat in treatment-naive patients with Gaucher disease type 1: post-hoc comparison to imiglucerase in a real- world setting[J]. Mol Genet Metab,2015, 114(2): 93
[22] 李丹, 黄建耿,杨丛莲, 等. LC-MS/MS法测定人血浆中氨氯地平浓度:改善色谱条件消除基质效应[J]. 药学学报, 2016, 51 (6): 1004
LI D, HUANG JG, YANG CL, et al. Quantification of amlodipine in human plasma by LC-MS/MS method: elimination of matrix effects by improving chromatographic conditions[J]. Acta Pharm Sin, 2016, 51 (6): 1004
[23] 张妍,宋媛媛, 宋文娅,等. 在高效液相色谱质谱联用检测血浆莎巴比星的基质效应影响因素[J]. 中国新药杂志,2016, 25(11):1241
ZHANG Y, SONG YY, SONG WY, et al. Factors influencing matrix effects of sabarubicin and its major metabolite in human plasma during liquid chromatography-tandem mass spectrometry analysis[J]. Chin J New Drugs, 2016, 25(11):1241
[24] GONZALEZ O, BLANCO ME, IRIARTE G, et al. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect[J]. J Chromatogr A, 2014, 1353:10
[25] 姚梦侃, 马秉亮, 马越鸣. 生物样品液质联用分析中的基质效应研究概况[J]. 药物分析杂志,2012, 30(12):2436
YAO MK, MA BL, MA YM. Overview of the matrix effect in quantitative liquid chromatography/mass spectrometry analyses of biological samples [J]. Chin J Pharm Anal,2012, 30(12):2436
[26] 向平, 沈敏, 卓先义. 在液相色谱-质谱分析中的基质效应[J]. 分析测试学报,2009,28(6): 753
XIANG P, SHEN M, ZHUO XY. Matrix effects in liquid chromatographic-mass spectrometric analysis[J]. J Instrum Anal,2009,28(6): 753
[27] 白梦如,申潜,马志媛,等. LC-MS/MS法同时测定人乳汁中贝他斯汀和羟氯喹的浓度[J]. 中国药房,2024, 35(11):1363
BAI MR, SHEN Q, MA ZY, et al. Simultaneous determination of bepotastine and hydroxychloroquine concentrations in human breast milk by LC-MS/MS[J]. China Pharm, 2024, 35(11):1363-1368
[28] 刘富邦,张瑛,王继芬,等. 实时直接分析串联质谱法检验血液和尿液中12个苯二氮类药物[J]. 药物分析杂志,2024, 44(6):960
LIU FB, ZHANG Y, WANG JF, et al. Determination of 12 benzodiazepines in blood and urine by DART-MS/MS method[J]. Chin J Pharm Anal,2024, 44(6):960
[29] 王成龙,刘佳,徐振林,等. 超高效液相色谱-串联质谱法检测6种样品基质中百草枯农药残留[J]. 药物分析杂志,2022, 42(12):2155
WANG LC, LIU J, XU ZL, et al. HPLC-MS/MS method for the quantification of vildagliptin in human plasma and its application [J]. Chin J Pharm Anal,2022, 42(12):2155
